The appointment comes as Africa intensifies efforts to strengthen its response to the ongoing Ebola outbreak while accelerating the development of African-led medicines, vaccines and outbreak-ready innovations.
The new CFO succeeds Henrik Bøggild, who left the company after three and a half years to pursue another professional opportunity.
Dr. Melly currently serves as Kenya’s cancer country counterpart lead for the International Atomic Energy Agency and is affiliated with several global oncology bodies, including the Union for International Cancer Control and the Association of American Cancer Institutes.
Ambassador Ratebaye brings decades of experience in diplomacy, public international law, governance, and multilateral negotiation.
The inaugural eight-member ASAG brings together experts in pathogen genomics, human genomics, bioinformatics, clinical genetics, precision medicine, ethics, and public health.
Zora brings a wealth of experience from his 15-year journey within Philips, during which he has established himself as a trusted leader across multiple markets in the region.
Prof. Osinbajo will help shape Africa’s presence in global health structures, design sustainable financing mechanisms for health systems, and promote regional manufacturing capabilities.
Pamba brings to the role a rich combination of frontline medical experience, executive leadership, and a proven track record of driving healthcare access across Africa.
Abdallah previously served as Chief Investment Officer and has maintained close involvement with Cambridge Health Group for several years.
She will oversee the pharmaceutical company’s operations across India, Bangladesh, Nepal, Sri Lanka, and Maldives while joining the Board of Boehringer Ingelheim India.